Damian Garde

Joy Yang, Head of Index Product Management at MarketVector Indexes, shares her market outlook amidst turbulent trade negotiations and the potential for rate cuts. Damian Garde, Bloomberg Health Reporter, discusses Merck’s anticipated $200 million loss due to tariffs and the challenges facing its HPV vaccine, Gardasil, in the competitive Chinese market. They dive into the broader implications of tariffs on the pharmaceutical sector and how companies are navigating these financial hurdles.

Damian Garde, Bloomberg News healthcare reporter, discusses Eli Lilly's promising new weight loss pill that's shaking up the market. The conversation reveals how this pill could rival the popular Ozempic, as it potentially offers a more convenient option. Garde explores the competitive landscape among pharmaceutical giants striving for a piece of the predicted $130 billion market. He also sheds light on the contrasting fortunes of Eli Lilly and UnitedHealth, highlighting the ongoing challenges in the healthcare industry.